Actuate Therapeutics Inc
NASDAQ:ACTUBiotechnology
Healthcare
$2.09 +2.96%
+$0.06 today
- Market cap
- $50.01M
- Beta
- 0.53
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$0.92
52W Low $1.58High $9.22
Volume 0.03M
Average 0.16M
Balance Sheet
Inspect the capital base behind the business.
Assets
$14.04M
FY 2025 · Annual
+50.6% YoYLiabilities
$6.11M
FY 2025 · Annual
-33.7% YoYEquity
$7.92M
FY 2025 · Annual
+7505.6% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $8.1M |
| Other Current | $385.4K |
| Total Current Assets | $8.5M |
| Other Non-current | $391.8K |
| Total Non-current Assets | $391.8K |
| Total Assets | $8.9M |
Analysis
Selected assets total $8.9M for Latest. The largest visible component is Cash & Equivalents at $8.1M, about 91.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | May 22, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 22, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 22, 2026 | |
| 8-K | Current report | May 22, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 22, 2026 |
How much cash does ACTU have?
Actuate Therapeutics Inc (ACTU) reported $13.16M in cash and equivalents in fiscal 2025.
How much debt does ACTU carry?
Actuate Therapeutics Inc (ACTU) reported $404,991.00 of total debt, with net debt of -$12.75M.
Continue the stock analysis
Jump to another research area for this company.